Postoperative Pulmonary Hemodynamics and Systemic Inflammatory Response in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI LTD
Citação
MEDIATORS OF INFLAMMATION, v.2022, article ID 3977585, 12p, 2022
Resumo
There is scarce information about the relationships between postoperative pulmonary hemodynamics, inflammation, and outcomes in pediatric patients with congenital cardiac communications undergoing surgery. We prospectively studied 40 patients aged 11 (8-17) months (median with interquartile range) with a preoperative mean pulmonary arterial pressure of 48 (34-54) mmHg who were considered to be at risk for postoperative pulmonary hypertension. The immediate postoperative pulmonary/systemic mean arterial pressure ratio (PAP/SAP(IPO), mean of first 4 values obtained in the intensive care unit, readings at 2-hour intervals) was correlated directly with PAP/SAP registered in the surgical room just after cardiopulmonary bypass (r=0.68, p < 0.001). For the entire cohort, circulating levels of 15 inflammatory markers changed after surgery. Compared with patients with PAP/SAP(IPO)& LE;0.40 (n=22), those above this level (n=18) had increased pre- and postoperative serum levels of granulocyte colony-stimulating factor (p=0.040), interleukin-1 receptor antagonist (p=0.020), interleukin-6 (p=0.003), and interleukin-21 (p=0.047) (panel for 36 human cytokines) and increased mean platelet volume (p=0.018). Using logistic regression analysis, a PAP/SAP(IPO)> 0.40 and a heightened immediate postoperative serum level of macrophage migration inhibitory factor (quartile analysis) were shown to be predictive of significant postoperative cardiopulmonary events (respective hazard ratios with 95% CIs, 5.07 (1.10-23.45), and 3.29 (1.38-7.88)). Thus, the early postoperative behavior of the pulmonary circulation and systemic inflammatory response are closely related and can be used to predict outcomes in this population.
Palavras-chave
Referências
- Abman SH, 2015, CIRCULATION, V132, P2037, DOI 10.1161/CIR.0000000000000329
- Adatia I., 2011, PEDIAT PULMONARY HYP, P209
- Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5
- Bakogiannis C, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2017.09.013
- Boehne M, 2017, J CARDIAC SURG, V32, P116, DOI 10.1111/jocs.12879
- Boneberg EM, 2002, INFLAMM RES, V51, P119, DOI 10.1007/PL00000283
- Brunner N, 2014, PULM CIRC, V4, P10, DOI 10.1086/674885
- Buchner K, 2003, J PATHOL, V201, P288, DOI 10.1002/path.1425
- Bui CB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01480
- Burke DL, 2009, AM J PHYSIOL-LUNG C, V297, pL238, DOI 10.1152/ajplung.90591.2008
- Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
- Chada M, 2008, PEDIATR PULM, V43, P851, DOI 10.1002/ppul.20851
- Chandler WL, 2003, THROMB RES, V112, P185, DOI 10.1016/j.thromres.2003.11.006
- Ribeiro ZVD, 2010, ARQ BRAS CARDIOL, V94, P592, DOI 10.1590/S0066-782X2010005000042
- Durandy Y, 2014, ARTIF ORGANS, V38, P11, DOI 10.1111/aor.12195
- Fujii Y, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9040081
- Gaies MG, 2014, PEDIATR CRIT CARE ME, V15, P529, DOI 10.1097/PCC.0000000000000153
- Hofer A., 2015, J CLINI EXPT CARDIOL, V6, DOI [10.4172/2155-9880.1000392, DOI 10.4172/2155-9880.1000392]
- IDE H, 1987, ANN THORAC SURG, V44, P277, DOI 10.1016/S0003-4975(10)62074-7
- Justus G, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2017.03.017
- Kameny RJ, 2016, ADV PULMONARY HYPERT, V15, P87
- Kawamura T, 1997, CAN J ANAESTH, V44, P38, DOI 10.1007/BF03014322
- Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026
- Kolte D, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009729
- Korniluk A, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/9213074
- Kozik DJ, 2006, ANN THORAC SURG, V81, pS2347, DOI 10.1016/j.athoracsur.2006.02.073
- Le Hiress M, 2015, AM J RESP CRIT CARE, V192, P983, DOI 10.1164/rccm.201402-0322OC
- Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206
- Lindberg L, 2002, J THORAC CARDIOV SUR, V123, P1155, DOI 10.1067/mtc.2002.121497
- Lotan D, 2001, ANN THORAC SURG, V71, P233, DOI 10.1016/S0003-4975(00)02020-8
- Maeda NY, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/7305028
- McBride WT, 1996, CYTOKINE, V8, P724, DOI 10.1006/cyto.1996.0096
- Nakano M, 2012, CLIN EXP IMMUNOL, V170, P94, DOI 10.1111/j.1365-2249.2012.04638.x
- Natanov R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205437
- O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
- Parmigiani A, 2012, J IMMUNOL, V188
- Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517
- Rivera IR, 2013, ECHOCARDIOGR-J CARD, V30, P952, DOI 10.1111/echo.12163
- Souza MFS, 2020, CYTOKINE, V134, DOI 10.1016/j.cyto.2020.155192
- Toyama S, 2008, J ANESTH, V22, P341, DOI 10.1007/s00540-008-0645-z
- Tu L., 2012, AM J RESP CRIT CARE, V187, pA1229, DOI [10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1229, DOI 10.1164/AJRCCM-CONFERENCE.2012.185.1_MEETINGABSTRACTS.A1229]
- VOELKEL NF, 1994, AM J RESP CELL MOL, V11, P664, DOI 10.1165/ajrcmb.11.6.7946395
- Zhang B, 2012, MICROVASC RES, V83, P205, DOI 10.1016/j.mvr.2011.09.014
- Zhang B, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/840737
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - LIM/31
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - LIM/31
Artigos e Materiais de Revistas Científicas - ODS/03